Caribou Biosciences, Inc. (CRBU)
2.36
+0.05
(+2.16%)
USD |
NASDAQ |
May 29, 16:00
2.355
0.00 (0.00%)
After-Hours: 20:00
Caribou Biosciences EPS Diluted (Quarterly) : -0.2617 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Sarepta Therapeutics, Inc. | 2.878 |
| Beam Therapeutics, Inc. | -0.9134 |
| Arrowhead Pharmaceuticals, Inc. | -0.932 |
| Oncolytics Biotech, Inc. | -0.0823 |
| Sangamo Therapeutics, Inc. | -0.0796 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -25.08M |
| Revenue (Quarterly) | 2.397M |
| Total Expenses (Quarterly) | 27.48M |
| Enterprise Value | 143.39M |
| Gross Profit Margin (Quarterly) | 72.92% |
| Profit Margin (Quarterly) | -1.05K% |
| Earnings Yield | -60.11% |
| Normalized Earnings Yield | -53.46 |